FMR LLC 13D and 13G filings for Enliven Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 09:03 am Purchase | 2024-02-08 | 13G | Enliven Therapeutics, Inc. ELVN | FMR LLC | 5,902,265 14.321% | 1,482,684 (+33.55%) | Filing |
| 2023-05-10 09:45 am Purchase | 2023-05-09 | 13G | Enliven Therapeutics, Inc. ELVN | FMR LLC | 4,419,581 10.749% | 4,419,581 (New Position) | Filing |